The Pituitary World News Podcast

In this podcast, Dr. Blevins reviews the side effects of dopamine agonist drugs. These are drugs that activate certain types of cells in the brain to regulate various functions, including hormone regulation, movement, and motivation. Dr. Blevins's discussion focuses on the drug cabergoline and its side effects, citing several research studies. This is a fascinating review of side effects you won't want to miss, even if you don't use or are unfamiliar with cabergoline and its use in treating prolactinomas. For more information on prolactinomas and other pituitary disorders, visit pituitaryworldnews.org [https://www.pituitaryworldnews.org/]. Stay tuned for an upcoming book on prolactinomas, scheduled for release later this year.  While you’re there, browse through the website for more resources and explore our current selection of books on Cushing’s syndrome, diabetes insipidus, vasopressin resistance, and hypopituitarism—available for purchase.  Additionally, a new book focusing on pituitary tumors will be released later this month. Explore. Learn. Stay Ahead. Visit us today!

Sometimes conversations take interesting turns and often lead to surprising and unexpected discussions. If you're a regular listener of the Pituitary Podcast, you may have caught a few of our live broadcasts where these unscripted discussion are common. Today I'm joined by Risa August, a patient and advocate and a frequent guest sharing her work, adventures and advocacy efforts, [https://pituitaryworldnews.org/?s=Risa+Heidt]for one of those engaging chats. In this podcast we explored the importance of listening. We also discussed the stories that spark the interest needed to capture the attention of people who may know little or nothing about pituitary conditions. With greater awareness, and since early diagnosis is such a game changer with these devastating conditions, perhaps more people will be mindful of the subtle signs that deserve medical attention — and maybe, just maybe, they'll ask the right questions that guide their doctors toward considering a potential pituitary diagnosis sooner rather than later.  Here'e another example of this discussion from a recent Grand Rounds Video with physicians and endocrine fellows [https://pituitaryworldnews.org/pituitary-grand-rounds-episode-8-acromegaly-insights-a-case-discussion-with-two-physicians-and-their-fellows/] discussing an acromegaly case. Click here [https://www.risaaugust.com/] to order the book and learn more about Risa's work.

Today's podcast is about an important Chiesi Rare Diseases initiative to learn more about the psychological, social, and emotional health issues facing acromegaly patients.  We talked to Stuart Siedman, Chiesi's Vice President of advocacy.  Stuart has an extensive background in rare diseases and a personal connection as an advocate.  This is an important subject. We hope you will help by participating in the survey.  Click here to take the survey [https://herspiegelconsulting.qualtrics.com/jfe/form/SV_3mGfDr2Jws2Xdci?source=PWN].

In today's podcast, we are excited to welcome Dr. Joanna Spencer-Segal, a research assistant professor at the Michigan Neuroscience Institute and an assistant professor in the Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes at the University of Michigan. She joins Dr. Lewis Blevins and me to discuss the promising new treatment options for acromegaly. Our conversation delves into the latest therapies, the challenges faced by practitioners, and the groundbreaking developments nearing final approval that could soon bring more exciting options to those living with this complex condition. You don't want to miss this insightful discussion!

I am pleased to welcome Dr. Scott Pescatore to the Pituitary Podcast.  In today's podcast, we discuss some of the work being done in the pituitary and adrenal space.  Dr. Pescatore's - and other industry leaders we've featured on the Pituitary Podcasts - opinions and points of view are essential to developing current and future therapies and potential new treatments affecting access to medications for pituitary disease.  By and large, these are the people who make the ultimate decisions on what medications are brought to market and how they support the people who need those therapies.  We are delighted to bring you Dr. Pescatore's perspectives. Don't miss this fascinating discussion.   Available Dr. Lewis Blevins new book Cushing's; a comprehensive guide to understanding a devastating disease.  Click here to buy your copy today [https://store.bookbaby.com/book/cushings]